Lowest Price Guaranteed
Pages
501
Last Updated
July 2026
View Count
15507
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
5.1. Executive Summary: Market Landscape
5.2. Executive Summary: Market Trends
5.3. Executive Summary: Market Forecast and Opportunity Analysis
6. INTRODUCTION
6.1. Overview of Cell Encapsulation
6.2. Type of Encapsulation Material
6.3. Methods of Encapsulation
6.4. Application Area of Cell Encapsulation
6.5. Advantages of Cell Encapsulation Technologies
6.6. Future Trends
7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Cell Encapsulation: Overall Market Landscape
7.2.1. Analysis by Type of Encapsulation Method
7.2.2. Analysis by Route of Administration
7.2.3. Analysis by Application Area
7.2.4. Analysis by Type of Material Used
7.2.5. Analysis by Therapeutic Area
7.2.6. Analysis by Year of Establishment
7.2.7. Analysis by Company Size
7.2.8. Analysis by Location of Headquarters
8. TECHNOLOGY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology and Key Parameters
8.3. Scoring Criteria
8.4. Overview of Peer Groups
8.5. Cell Encapsulation Technologies: Technology Competitiveness Analysis
8.5.1. Cell Encapsulation Technologies: Provided by Players Headquartered in North America (Peer Group I)
8.5.1.1. Cell Encapsulation Technologies: Overview of Players Providing Leading Technologies (Peer Group I)
8.5.2. Cell Encapsulation Technologies: Provided by Players Headquartered in Europe (Peer Group II)
8.5.2.1. Cell Encapsulation Technologies: Overview of Players Providing Leading Technologies (Peer Group II)
8.5.3. Cell Encapsulation Technologies: Provided by Players Headquartered in Asia-Pacific and Rest of the World (Peer Group III)
8.5.3.1. Cell Encapsulation Technologies: Overview of Players Providing Leading Technologies (Peer Group III)
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Beta-Cell
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Recent Initiatives
* Similar details are presented for other companies mentioned below (based on information in the public domain)
9.3. Betalin Therapeutics
9.4. Beta-O2 Technologies
9.5. Diatranz Otsuka
9.6. Neurotech
9.7. Sernova
9.8. Semma Therapeutics
9.9. ViaCyte
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Cell Encapsulation: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Key Technology: Analysis by Number of Partnerships
10.3.5. Key Therapeutic Area: Analysis by Number of Partnerships
10.3.6. Most Active Players: Analysis by Number of Partnerships
10.4. Analysis by Geography
10.4.1. Local and International Agreements
10.4.2. Intracontinental and Intercontinental Agreements
11. FUNDING AND INVESTMENTS
11.1. Chapter Overview
11.2. Funding Models
11.3. Funding Lifecycle Analysis
11.4. Investment Case: Risk and Returns
11.5. Cell Encapsulation: List of Funding and Investments
11.5.1. Analysis by Year of Investment
11.5.2. Analysis by Type of Funding
11.5.3. Analysis by Year of Investment and Type of Funding
11.5.4. Analysis by Year of Amount Invested
11.5.5. Analysis by Amount Invested and Type of Funding
11.5.6. Analysis by Geography
11.5.7. Most Active Players: Analysis by Number of Instances
11.5.8. Most Active Players: Analysis by Amount Invested
11.5.9. Most Active Investors: Analysis by Number of Instances
11.5.10. Most Active Investors: Analysis by Number of Instances
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Cell Encapsulation Market: Patent Analysis
12.3.1. Analysis by Publication Year
12.3.2. Analysis by Type of Patent
12.3.3. Analysis by Type of Patent and Publication Year
12.3.4. Analysis by Type of Applicant
12.3.5. Analysis by Application Year
12.3.6. Analysis by Patent Jurisdiction (Region)
12.3.7. Analysis by Patent Jurisdiction (Country)
12.3.8. Analysis by Patent Age
12.3.9. Leading Industry Players: Analysis by Number of Patents
12.3.10. Leading Non-Industry Players: Analysis by Number of Patents
12.3.11. Leading Individual Assignees: Analysis by Number of Patents
12.3.12. Analysis by CPC Symbols
12.4. Cell Encapsulation: Patent Benchmarking Analysis
12.5. Patent Valuation Analysis
13. GRANT ANALYSIS
13.1. Chapter Overview
13.2. Types of Grants
13.3. Types of Grants Applications
13.4. Key Factors for Consideration
13.5. Stages of Grants
13.6. Methodology and Key Parameters
13.7. Cell Encapsulation: Grants Analysis
13.7.1. Analysis by Year of Grant Award
13.7.2. Analysis by Amount Awarded
13.7.3. Analysis by Funding Institute Center
13.7.4. Analysis by Purpose of Grant Award
13.7.5. Analysis by Type of Grant Application
13.7.6. Analysis by Activity Code
13.7.7. Analysis by Study Section Involved
13.7.8. Analysis by Support Period
13.7.9. Most Popular NIH Departments: Analysis by Number of Grants
13.7.10. Type of Recipient Organizations: Analysis by Number of Grants
13.7.11. Prominent Program Officers: Analysis by Number of Grants
13.7.12. Popular Recipient Organizations: Analysis by Number of Grants
13.7.13. Popular Recipient Organizations: Analysis by Grant Amount
14. MARKET IMPACT ANALYSIS
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. GLOBAL CELL ENCAPSULATION MARKET
15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Global Cell Encapsulation Market, Forecasted Estimates (till 2035)
15.4. Roots Analysis Perspective on Market Growth
15.5. Scenario Analysis
15.5.1. Conservative Scenario
15.5.2. Optimistic Scenario
15.6. Key Market Segmentations
16. CELL ENCAPSULATION MARKET, BY TYPE OF ENCAPSULATION MATERIAL
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Cell Encapsulation Market: Distribution by Type of Encapsulation Material
16.3.1. Cell Encapsulation Market for Natural Polymers, Forecasted Estimates (till 2035)
16.3.2. Cell Encapsulation Market for Synthetic Polymers, Forecasted Estimates (till 2035)
16.4. Data Triangulation and Validation
17. CELL ENCAPSULATION MARKET, BY TYPE OF ENCAPSULATION METHOD
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Cell Encapsulation Market: Distribution by Type of Encapsulation Method
17.3.1. Cell Encapsulation Market for Macrencapsulation, Forecasted Estimates (till 2035)
17.3.2. Cell Encapsulation Market for Microencapsulation, Forecasted Estimates (till 2035)
17.3.3. Cell Encapsulation Market for Nanoencapsulation, Forecasted Estimates (till 2035)
17.4. Data Triangulation and Validation
18. CELL ENCAPSULATION MARKET, BY TYPE OF MANUFACTURING TECHNIQUE
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Cell Encapsulation Market: Distribution by Type of Manufacturing Technique
18.3.1. Cell Encapsulation Market for Co-axial Airflow, Forecasted Estimates (till 2035)
18.3.2. Cell Encapsulation Market for Electrostatic Dripping, Forecasted Estimates (till 2035)
18.3.3. Cell Encapsulation Market for Semi-permeable Membrane Systems, Forecasted Estimates (till 2035)
18.3.4. Cell Encapsulation Market for Simple Dripping, Forecasted Estimates (till 2035)
18.3.5. Cell Encapsulation Market for Other Techniques, Forecasted Estimates (till 2035)
18.4. Data Triangulation and Validation
19. CELL ENCAPSULATION MARKET, BY TYPE OF TECHNOLOGY
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Cell Encapsulation Market: Distribution by Type of Technology
19.3.1. Cell Encapsulation Market for 3D Printing, Forecasted Estimates (till 2035)
19.3.2. Cell Encapsulation Market for Electrostatic Spray, Forecasted Estimates (till 2035)
19.3.3. Cell Encapsulation Market for Emulsification, Forecasted Estimates (till 2035)
19.3.4. Cell Encapsulation Market for Extrusion, Forecasted Estimates (till 2035)
19.3.5. Cell Encapsulation Market for Jet Cutting, Forecasted Estimates (till 2035)
19.3.6. Cell Encapsulation Market for Other Technologies, Forecasted Estimates (till 2035)
19.4. Data Triangulation and Validation
20. CELL ENCAPSULATION MARKET, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Cell Encapsulation Market: Distribution by Application Area
20.3.1. Cell Encapsulation Market for Cell Transplantation, Forecasted Estimates (till 2035)
20.3.2. Cell Encapsulation Market for Drug Delivery, Forecasted Estimates (till 2035)
20.3.3. Cell Encapsulation Market for Probiotics Delivery, Forecasted Estimates (till 2035)
20.3.4. Cell Encapsulation Market for Regenerative Medicine, Forecasted Estimates (till 2035)
20.3.5. Cell Encapsulation Market for Research and Diagnostics, Forecasted Estimates (till 2035)
20.4. Data Triangulation and Validation
21. CELL ENCAPSULATION MARKET, BY END USER
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Cell Encapsulation Market: Distribution by End User
21.3.1. Cell Encapsulation Market for Academic and Research Institutes, Forecasted Estimates (till 2035)
21.3.2. Cell Encapsulation Market for Biotechnology and Pharmaceutical Companies, Forecasted Estimates (till 2035)
21.3.3. Cell Encapsulation Market for Other End Users, Forecasted Estimates (till 2035)
21.4. Data Triangulation and Validation
22. CELL ENCAPSULATION MARKET, BY GEOGRAPHICAL REGIONS
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Cell Encapsulation Market: Distribution by Geographical Regions
22.3.1. Cell Encapsulation Market in North America: Forecasted Estimates (till 2035)
22.3.1.1. Cell Encapsulation Market in the US: Forecasted Estimates (till 2035)
22.3.1.2. Cell Encapsulation Market in Canada: Forecasted Estimates (till 2035)
22.3.2. Cell Encapsulation Market in Europe: Forecasted Estimates (till 2035)
22.3.2.1. Cell Encapsulation Market in France: Forecasted Estimates (till 2035)
22.3.2.2. Cell Encapsulation Market in Germany: Forecasted Estimates (till 2035)
22.3.2.3. Cell Encapsulation Market in Italy: Forecasted Estimates (till 2035)
22.3.2.4. Cell Encapsulation Market in Spain: Forecasted Estimates (till 2035)
22.3.2.5. Cell Encapsulation Market in the UK: Forecasted Estimates (till 2035)
22.3.2.6. Cell Encapsulation Market in Rest of Europe: Forecasted Estimates (till 2035)
22.3.3. Cell Encapsulation Market in Asia-Pacific: Forecasted Estimates (till 2035)
22.3.3.1. Cell Encapsulation Market in China: Forecasted Estimates (till 2035)
22.3.3.2. Cell Encapsulation Market in India: Forecasted Estimates (till 2035)
22.3.3.3. Cell Encapsulation Market in Japan: Forecasted Estimates (till 2035)
22.3.3.4. Cell Encapsulation Market in Australia: Forecasted Estimates (till 2035)
22.3.3.5. Cell Encapsulation Market in South Korea: Forecasted Estimates (till 2035)
22.3.3.6. Cell Encapsulation Market in Rest of Asia-Pacific: Forecasted Estimates (till 2035)
22.3.4. Cell Encapsulation Market in Middle East and Africa: Forecasted Estimates (till 2035)
22.3.4.1. Cell Encapsulation Market in Saudi Arabia: Forecasted Estimates (till 2035)
22.3.4.2. Cell Encapsulation Market in UAE: Forecasted Estimates (till 2035)
22.3.4.3. Cell Encapsulation Market in Egypt: Forecasted Estimates (till 2035)
22.3.5. Cell Encapsulation Market in Latin America: Forecasted Estimates (till 2035)
22.3.5.1. Cell Encapsulation Market in Brazil: Forecasted Estimates (till 2035)
22.3.5.2. Cell Encapsulation Market in Mexico: Forecasted Estimates (till 2035)
22.3.5.3. Cell Encapsulation Market in Rest of Latin America: Forecasted Estimates (till 2035)
22.4. Market Dynamics Assessment
22.4.1. Penetration-Growth (P-G) Matrix
22.5. Data Triangulation and Validation
23. PORTER’S FIVE FORCES
23.1. Chapter Overview
23.2. Methodology and Assumptions
23.3. Key Parameters
23.3.1. Threat of New Entrants
23.3.2. Bargaining Power of Buyers
23.3.3. Bargaining Power of Service Providers
23.3.4. Threats of Substitute Products
23.3.5. Rivalry Among Existing Competitors
23.4. Concluding Remarks
24. CONCLUDING REMARKS
25. EXECUTIVE INSIGHTS
25.1. Company A
25.1.1. Company Overview
25.1.2. Interview Transcript: Chief Scientific Officer
25.2. Company B
25.2.1. Company Overview
25.2.2. Interview Transcript: Business Developer
25.3. Company C
25.3.1. Company Overview
25.3.2. Interview Transcript: Chief Scientist
25.4. Company D
25.4.1. Company Overview
25.4.2. Interview Transcript: Business Development Manager
25.5. Company E
25.5.1. Company Overview
25.5.2. Interview Transcript: Chief Executive Officer
25.6. Company F
25.6.1. Company Overview
25.6.2. Interview Transcript: Former President and Chief Executive Officer
25.7. Company G
25.7.1. Company Overview
25.7.2. Interview Transcript: Founder and Chief Executive Officer
25.8. Company H
25.8.1. Company Overview
25.8.2. Interview Transcript: Former Chief Executive Officer
25.9. Company I
25.9.1. Company Overview
25.9.2. Interview Transcript: Chief Executive Officer
25.10. Company J
25.10.1. Company Overview
25.10.2. Interview Transcript: Vice President, Medical Oncology
25.11. Company K
25.11.1. Company Overview
25.11.2. Interview Transcript: Chief Executive Officer
26. APPENDIX I: TABULATED DATA
27. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS